HDAC6 and amyotrophic lateral sclerosis: Rossaert and colleagues (2019) also demonstrated that at 100 mg/kg, ACY-738 altered class 1 HDAC activity, and improved survival in HDAC6 knock out mice, implicating global changes to histone modifications to rescue ALS (Rossaert et al., 2019).